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High-quality nucleic acids are critical for optimal PCR-based diagnostics and pathogen detection. Rapid sam-
ple processing time is important for the earliest administration of therapeutic and containment measures, es-
pecially in the case of biothreat agents. In this context, we compared the Fujifilm QuickGene-Mini80 to
Qiagen's QIAamp Mini Purification kits for extraction of DNA and RNA for potential use in austere settings.
Qiagen (QIAamp) column-based extraction is the currently recommended purification platform by United
States Army Medical Research Institute for Infectious Diseases for both DNA and RNA extraction. However,
this sample processing system requires dedicated laboratory equipment including a centrifuge. In this
study, we investigated the QuickGene-Mini80, which does not require centrifugation, as a suitable platform
for nucleic acid extraction for use in resource-limited locations. Quality of the sample extraction was evalu-
ated using pathogen-specific, real-time PCR assays for nucleic acids extracted from viable and γ-irradiated
Bacillus anthracis, Yersinia pestis, vaccinia virus, Venezuelan equine encephalitis virus, or B. anthracis spores
in buffer or human whole blood. QuickGene-Mini80 and QIAamp performed similarly for DNA extraction re-
gardless of organism viability. It was noteworthy that γ-irradiation did not have a significant impact on
real-time PCR for organism detection. Comparison with QIAamp showed a less than adequate performance
of the Fujifilm instrument for RNA extraction. However, QuickGene-Mini80 remains a viable alternative to
QIAamp for DNA extraction for use in remote settings due to extraction quality, time efficiency, reduced
instrument requirements, and ease of use.
Published by Elsevier B.V.
1. Introduction
Biothreat agents, including Bacillus anthracis, Yersinia pestis, Variola
virus (vaccinia virus is a surrogate for Variola virus, the causative
agent of smallpox), and Venezuelan equine encephalitis virus (VEEV),
represent significant public health risks due to high pathogenicity and
potential for aerosolization (Roy et al., 2010). Rapid and specific identi-
fication of these pathogens is critical for initiation of appropriate con-
tainment and therapeutic measures as prognosis is directly impacted
by time to diagnosis. This is especially true for the potential of an inten-
tional release of a biological agent. In this context, real-time PCR is cur-
rently implemented for the highly specific identification of pathogens in
both clinical and environmental settings (Belgrader et al., 1998;
Christensen et al., 2006; Higgins et al., 1998; Makino et al., 2001; Ryu
et al., 2003; Shchelkunov et al., 2011; Skottman et al., 2007; Tomaso
et al., 2008).
Numerous factors inherent to clinical and environmental matrices
can inhibit downstream molecular diagnostic applications, such as
real-time PCR (Rossen et al., 1992; Wilson, 1997). The quality of the
nucleic acids purified from a clinical or environmental sample is
critical for the optimal performance of these types of assays. This
purification step is especially important for diagnostic pathogen de-
tection where sensitivity is critical. Specific inhibitors of real-time
PCR diagnostics include hemoglobin (Akane et al., 1994) and polysac-
charides (Monteiro et al., 1997) from blood as well as proteins from
food samples (Rossen et al., 1992) and humic and fulvic acids (Tsai
and Olson, 1992) from environmental samples. Beyond inhibitor
removal, release of target DNA/RNA is requisite for optimal molecular
assay kinetics. For bacteria and spores, efficient lysis of the cell wall is
needed; however, these harsh lysing conditions must be tempered to
maintain the integrity of the extracted nucleic acids (Rantakokko-Jalava
and Jalava, 2002). Because of all these factors, most diagnostic applica-
tions of real-time PCR are accompanied by sample processing and
nucleic acid extraction.
Our lab has extensive experience using Qiagen's QIAamp Mini
Extraction Kits for DNA and RNA extraction of biothreat organisms.
These platforms perform well for extraction of clinical and environ-
mental samples; however, the extraction protocols used require cap-
ital investment in equipment (ex. a centrifuge) as well as time for
processing (90+min). While these kits are adequate for reference
laboratory use, this study sought to evaluate additional extraction
platforms that could yield similar results to the tested Qiagen kits
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but required less resources and potentially could reduce the time-to-
answer. In this context, we evaluated Fujifilm's QuickGene-Mini80
(QG-Mini80) platform as a possible solution in comparison to
QIAamp. To test the applicability of the QG-Mini80 for clinical biothreat
agent detection, nucleic acids were isolated from buffer and human
whole blood containing the serially diluted biothreat agents B. anthracis,
Y. pestis, vaccinia virus (VACV), and VEEV as well as B. anthracis spores.
Established real-time PCR-based assays were conducted to compare
purification efficacies as well as agent detectability from the extracted
nucleic acids.
2. Materials and methods
2.1. Bacterial and viral strains
Biothreat organisms maintained at United States Army Medical
Research Institute for Infectious Diseases (USAMRIID) or purchased
through the Critical Reagents Program (CRP, Frederick, MD), a re-
agents resource for biodefense research, were used for these studies.
Viable or γ-irradiated bacteria included B. anthracis Ames strain
vegetative cells and Y. pestis strain CO92 bacteria as well as
γ-irradiated B. anthracis Ames strain spores. Viruses included viable
VACV strain SALK 17633, γ-irradiated VACV strain Elstree/Lister,
and viable or γ-irradiated VEEV strain Trinidad donkey (IA/IB).
Organism was diluted into the appropriate matrix, either buffer
[Dulbecco's phosphate-buffered saline (PBS)] or human whole blood
(Bioreclamation, NY), to generate a stock, and this stockwas then serially
diluted in the samematrix. B. anthracisAmes strain spores were diluted
into molecular grade water to prevent clumping, and concentrations
of viable spores were determined using sheep blood agar plates
(Remel, Lenexa, KS) incubated at 37 °C for 24 h. From this stock, se-
rial dilutions of spores in water were made, and diluted spores were
sonicated using the Branson 2510 Ultrasonic Cleaner (Danbury, CT).
Previously quantified γ-irradiated spores were diluted into molecu-
lar grade water and sonicated, and serial dilutions into molecular
grade water were made.
2.2. Fujifilm QuickGene-Mini80 platform
DNA from the diluted organisms or spores was isolated using the
QG-Mini80 DNA Tissue Kit. The manufacturer's instructions were
modified from the recommendedprotocol. Specifically, microcentrifuge
tubes containing 100 μl of sample (organism diluted in buffer or blood),
180 μl of lysis buffer (contains guanidine hydrochloride), and 20 μl of
proteinase K were mixed and incubated for 2 min at 55 °C. After this
incubation, 200 μl of ethanol (>99%) was added and mixed, and the
sample was applied to the column. Samples were washed three
times with wash buffer, and DNA was subsequently eluted in 100 μl of
elution buffer after a 90 sec incubation at room temperature. VEEV
RNA was extracted using the QG-Mini80 RNA Tissue Kit S II. Microce-
ntrifuge tubes containing 70 μl of sample and 35 μl of buffer SRT were
combined. Thirty-five μl of ethanol (>99%) was added to the lysate,
mixed, and the sample was applied to the cartridge with three subse-
quent washes of buffer WRT. RNA was eluted in 100 μl of buffer CRT
after a 120 sec incubation at room temperature.
2.3. Qiagen QIAamp mini platform
DNA from the serially diluted organisms was manually isolated
using Qiagen's DNA mini platform with modifications to man-
ufacturer's instructions. Specifically, microcentrifuge tubes containing
100 μl of sample, 80 μl of PBS, 200 μl of buffer AL (contains guanidine
hydrochloride), and 20 μl of proteinase K (17.8 mg/ml) were com-
bined and incubated at 55 °C for 60 min. After this incubation,
210 μl of ethanol (>99%) was added. Samples were vortexed and
loaded onto a Qiagen spin column for centrifugation followed by
washing with buffers AW1 and AW2. After centrifugation to dry the
samples, DNA was eluted for 5 min at 70 °C using 100 μl of preheated
AE buffer (10 mM Tris-CL, 0.5 mM EDTA, pH 9.0). VEEV RNA from a
70 μl sample was extracted using Qiagen's QIAamp RNA Blood Mini
Kit according to the manufacturer's instructions.
2.4. Extraction efficiency measurement
In order to compare the extraction efficiencies for both platforms,
γ-irradiated B. anthracis vegetative cells were serially diluted 1:10 in
buffer from 1×107 to 1×104 colony forming units (CFU)/sample.
DNA was extracted from each sample in triplicate using either the
QIAamp DNA Mini kit or the QG-Mini80 DNA extraction kit. DNA
was quantified in triplicate, one sample per extraction for a total of
three replicates, using the Quant-iT PicoGreen dsDNA Reagent (Life
Technologies, Grand Isle, NY) according to the manufacturer's in-
structions. Statistical significance in DNA extraction for each platform
was evaluated using a two-tail t-test at each sample dilution, assuming
equal variance.
2.5. Evaluation of the extracted material by agent-specific real-time PCR
All samples were evaluated for successful PCR amplification via
real-time PCR using the R.A.P.I.D. thermocycler (Idaho Technology,
Inc., Salt Lake City, UT). Five μls of extracted nucleic acids were used
for each PCR reaction in a 20 μl reaction volume. For all of the
DNA-extracted organisms, the cycling conditions were 45 cycles of
95 °C for 0 s and 60 °C for 20 s. DNA extracted from B. anthracis
Ames was detected using a pX01-specific assay as previously de-
scribed (Christensen et al., 2006). Y. pestis was detected using a PIM-
specific assay as previously described (Christensen et al., 2006). VACV
primers targeting the polymerase were used at a final concentration
of 0.5 mM for VACA25L-F151 (5′-CACCTCCACCAAAACCTAAAACTC)
and VACA25L-R231 (5′-AAAATgggCgTggATTgTTAAC). VACV probe
VACA25L-p193S-MGB (5′-AgACgTCCgATTCTAT) was used at 0.1 mM.
VEEV was detected using primers and probe targeting nsp2 (Parker
et al., 2010). Primers VEENSP2U (5′-CTTggCAAACCTCTggCAgC) and
VEENSP2L (5′-ATACCCACTCggTTCCAgCg) were used at a final concen-
tration of 0.9 mM, and probe VEENSP2P1A (5′-CTCTTCATgCAATgCC
CTTCTCCTgTCA) was used at a final concentration of 0.06 mM. For
VEEV, the cycling conditions included a reverse transcriptase step of
50 °C for 15 min followed by a 5-min hold at 95 °C and 45 cycles of
95 °C for 0 s, 60 °C for 20 s using the SuperScript One-Step RT-PCR sys-
tem (Life Technologies, Grand Island, NY) supplemented with 0.25 mM
BSA (Sigma-Aldrich, St. Louis, MO). All probes were labeled with FAM/
TAMRA. A real-time PCR sample was considered positive if the CT
value was b40 cycles. Negative results were noted if the number of
cycles were >40 or if no CT was observed. If any fluorescence was ob-
served for the no template control (NTC), the runwas considered invalid.
For each analysis, we correlated real-time PCR CT values to the rel-
ative concentration of target, thus lower CT values correlated to an in-
crease in target material. For each sample, three separate extractions
were conducted, and nucleic acids were quantified in triplicate with
one replicate coming from each extraction. The limit of detection
(LOD) or lowest amount of pathogen detectable was determined to
be the target organism concentration where all three extracted sam-
ples resulted in a positive result by real-time PCR.
3. Results
3.1. Platform ease of use, general characteristics, and extraction efficiencies
Initial evaluations focused on assessing general physical and fiscal
parameters as well as defining any differences in extraction efficiency
between the QG-Mini80 and QIAamp using B. anthracis DNA extrac-
tions. For the QG-Mini80, up to eight samples could be extracted in
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approximately 15–20 min, compared to 108 min for 16 samples
using the QIAamp DNA extraction kit. Averaged times were based
on 48 B. anthracis DNA extractions. With regard to cost, both plat-
forms are similarly priced per sample at USD $2.60 for the QG-
Mini80 and $2.45 for the QIAamp DNA extraction kit. Overall, QIAamp
showed slightly better DNA recovery compared to QG-Mini80, with
statistically significant differences at the 105 (p=0.010) and the
106 (p=0.04) CFU dilutions (Fig. 1). Beyond these variations in ex-
traction efficiency, the principal difference noted from these data
was the time of extraction, with QIAamp taking an average of about
90 min longer than QG-Mini80 over the course of 48 samples. A com-
parison of the extraction efficiency for RNA was also performed using
the Quant-iT RiboGreen RNA Reagent and Kit (Life Technologies), but
the sensitivity of the RiboGreen kit was insufficient to detect the
level of input RNA used in this study (data not shown). During
this evaluation and all subsequent analyses, we did not observe
cross-contamination between the samples with either platform; none
of the negative control reactions produced false positive results.
3.2. DNA and RNA extraction from buffer and blood using γ-irradiated
pathogen
The lowest amount of detectable pathogen was determined for
each γ-irradiated pathogen in buffer in order to optimize the
QG-Mini80 protocol and initially evaluate the quality of the extracted
nucleic acids from phylogenetically diverse biothreat agents (Table 1).
Buffer was used for this initial evaluation as it is a simple matrix and
contains limited inhibitors of PCR. Pathogen-specific real-time PCR
assays were used to assess extraction efficiencies, comparing the CT
values at different pathogen dilutions. Results from this comparison
varied and suggested better extraction efficiency with QIAamp. For ex-
ample, the LOD for γ-irradiated Y. pestis was 50 CFU/ml for both plat-
forms; however, CT values for the QIAamp-extracted DNA were one to
two cycles earlier. Positive samples were detected in two of the
three samples at the next lower dilution, 10 CFU/ml (Table 1). Similarly,
LODs for VACV (DNA) and VEEV (RNA) were lower for QIAamp [at
5×102 and 1×103 plaque forming units (PFU)/ml, respectively] than
QG-Mini80 (at 5×103 for both viruses) extracted material. Interesting-
ly, the QG-Mini80 extracted material resulted in a lower amount of
detectable pathogen, 50 CFU/ml, for B. anthracis Ames vegetative cells
than the QIAamp at 100 CFU/ml (Table 1).
Defining the clinical and diagnostic applicability of the QG-Mini80
platform was another central objective for this research. To test this
aspect, both QG-Mini80 and QIAamp were evaluated for extraction
efficiency using γ-irradiated organism spiked into human whole
blood as a representative clinical matrix. Similar to observations in
buffer, QIAamp-purified material from blood showed better detectabil-
ity than similar samples extracted using the QG-Mini80 for all agents
testedwith the exception of VACV (Table 1). In this case, both platforms
yielded similar amounts of detectable VACV nucleic acid at 5×102 PFU/
ml; however, the CT value for the QIAamp extracted material was two
cycles lower than the QG-Mini80 extracted material. Furthermore, for
QIAamp's B. anthracis extraction, the detectable amount of DNA was
lower than the QG-Mini80 (50 and 100 CFU/ml, respectively) even
though two of three samples were positive at 50 CFU/ml for the
QG-Mini80-extracted material. Overall, the buffer and whole blood
data suggested better extraction efficiency for QIAamp purification
compared to QG-Mini80.
3.3. DNA and RNA extraction from buffer and blood using viable pathogen
Evaluations with γ-irradiated biothreat agents suggested that the
QIAamp performed slightly better using the assessed real-time PCR
assays; however, this analysis did not address any impact the irradia-
tion process may have had on the nucleic acid material before extrac-
tion. To assess if the QG-Mini80 and QIAamp protocols might perform
differently with non-irradiated material, we evaluated serially diluted
viable organisms in human whole blood (Table 2). Both platforms
yielded similar detectable amounts of nucleic acid for Y. pestis at
5×101 CFU/ml and VACV at 5×102 PFU/ml (Table 2). QG-Mini80
performed better than QIAamp at extracting viable B. anthracis from
whole blood, with detectable nucleic acid from 50 to 5×102 CFU/ml,
respectively. These results were significantly contrasted by results
with viable VEEV. After several evaluationswith twodifferent viral stocks
and at titers of 1×106 PFU/ml, the QG-Mini80was unable to consistently
extract detectable levels of VEEV RNA (Table 2 and data not shown).
3.4. Evaluation of extraction platforms for spore DNA isolation
The overall trend of lower sensitivities with QG-Mini80 suggested
this method may not be adequate for extracting some of the more re-
calcitrant biothreat samples. To test this hypothesis, we evaluated
DNA extraction on both platforms followed by real-time PCR for
γ-irradiated and viable B. anthracis spores serially diluted in water.
Fig. 1. Comparison of the amount of DNA recovered following serial dilution of
γ-irradiated B. anthracis in buffer. Triplicate serial dilutions of γ-irradiated B. anthracis
in buffer were purified with either the QG-Mini80 or the QIAamp DNA extraction kit.
The amount of DNA recovered was quantified (one sample per replicate) using the
Quant-iT PicoGreen dsDNA reagent. Statistical differences were measured using a t-test,
and * is a p value of b0.05.
Table 1
Real-time PCR based (CT) evaluation of the QuickGene-Mini80 and QIAamp purification
platforms of γ-irradiated biothreat agents diluted in buffer and whole blood.
Organism CFU/
PFU/ml
CT values for QG-Mini80a CT values for QIAampa
Buffer Blood Buffer Blood
B. anthracis 1000 30.21±0.43 31.70±0.23 30.73±0.55 30.17±0.32
500 33.10±0.39 31.66±0.18 31.81±0.45 30.73±0.46
100 35.15±0.49 33.13±0.47 34.79±0.44 33.08±0.20
50 35.92±0.91 33.68b 34.51b 33.15±0.75
10 37.43c 33.56c 37.32c 33.40b
Y. pestis 1000 30.44±0.34 30.41±0.73 28.97±0.43 29.13±0.23
500 31.97±0.59 31.90±0.33 29.94±0.33 30.35±0.39
100 33.42±0.81 34.16±0.98 32.59±0.07 32.94±0.53
50 34.95±0.35 34.46±0.96 34.02±0.50 33.78±0.92
10 nd 36.06b 36.50b 35.74±0.78
VACV 50,000 31.20±0.06 27.29±0.86 29.93±0.18 25.37±2.12
10,000 33.83±0.45 30.35±0.47 32.67±0.30 28.60±0.53
5000 35.48±1.67 31.78±0.47 33.25±0.39 29.22±0.22
1000 36.58c 34.64±0.22 35.72±1.31 32.82±0.51
500 37.49b 34.92±1.40 35.87±0.62 32.85±0.41
VEEV 50,000 30.93±0.97 32.42±0.16 29.14±0.17 28.16±0.22
10,000 31.71±1.06 32.35±0.83 30.82±1.81 29.52±0.69
5000 32.93±0.26 nd 31.97±0.07 31.17±0.53
1000 32.39c nd 32.91±0.18 31.56±0.63
± is the standard deviation of one real-time PCR assay from three replicates; nd = not
detected.
a A positive sample had a CT value b40 cycles, and a negative sample had a CT value
of >40 cycles.
b Two of three replicates gave valid results.
c One of three replicates gave valid results.
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The lowest amount of detectable sporematerial extractedwith QIAamp
was 5×102 CFU/ml compared to 5×103 CFU/ml with the QG-Mini80,
supporting this hypothesis (Table 3). Data with viable B. anthracis
Ames spores showed a similar trend, although with less of a disparity
between the detectable amounts of input spores.
4. Discussion
In the event of an infection with an unknown agent, rapid patho-
gen detection is critical for containment and efficacious treatment.
For diagnostics and real-time PCR detection of etiologic agents,
our current standard extraction methods are Qiagen QIAamp DNA
Mini Kit and QIAamp Blood RNA Mini Kit. These platforms utilize
chaotropic lysis and silica-gel based nucleic acid binding using centri-
fugation for sample binding, washing, and nucleic acid elution. While
this method yields excellent nucleic acids, the process is time con-
suming (approximately 2 h from sample to extracted material) and
requires equipment, such as a centrifuge, that limits the use of these
platforms in resource-limited settings. Fujifilm's QG-Mini80 platform
for DNA and RNA extraction is a potential alternative to QIAamp for
nucleic acid extraction. Rose et al. recently described the QG-Mini80,
along with the Instagene Only (Bio-Rad, Hercules, CA), as the easiest
to use among 8 differentmethods they evaluated for Bacillus atrophaeus
spore DNA extraction (Rose et al., 2011). This technology utilizes similar
chaotropic lysis and a thin, silica-based membrane for nucleic acid
extraction but, instead of centrifugation, uses positive pressure for
sample application, membrane washing, and elution. Additionally,
the QG-Mini80 has short sample processing time (approximately
15–20 min for eight samples), a small footprint, greater ease of use,
and minimal power requirements. The objective of this research was
to assess the QG-Mini80 platform for the quality of nucleic acid extrac-
tion within a clinical context for use in austere settings.
Comparison of the extraction efficiencies suggested a trend of bet-
ter yields for the QIAamp DNA Mini Kit compared to QG-Mini80, es-
pecially at lower target DNA concentrations. This could be the result
of several differences between the platforms, including membrane
size and different lysing/binding/washing chemistries. The QG-Mini80
filter is approximately 80 μm in thickness compared to the typical silica
membrane of up to 1000 μm. While Fujifilm advertises equivalent
surface area due to the porosity of its membrane, the reduced DNA
recovery for the QG-Mini80 suggests either a reduced binding poten-
tial compared to the canonical spun glass fiber columns of QIAamp or
a less efficient processing, i.e. lysis of the sample or removal of PCR
inhibitors. Regardless of the specific reasons for the reduced DNA re-
covery, this did not directly correlate to less effective detection of the
extracted material. This is demonstrated with viable B. anthracis in
a clinical matrix where overall sensitivity in downstream PCR
reactions was better with QG-Mini80 extractions compared to
QIAamp. It is possible that a more comprehensive study comparing
QG-Mini80 and QIAamp might show more difference or similarity
in the detectability of extracted materials; however, the presented
data show the QG-Mini80 is suitable for use in remote environments
in the clinical arena for DNA-based organisms. In general, QG-Mini80
and QIAamp resulted in roughly comparable sensitivities for the
extracted material with cross-platform differences being only 1-log,
and more often a 1/2‐log, in disparity for DNA-based organisms.
Similar results were observed by Rose et al., who compared 8 dif-
ferent DNA extraction platforms for extraction efficiency using pow-
der, liquid, solid, and swabs as the matrix type. While QIAamp was
not evaluated in this study, the QG-Mini80 performed acceptably
(ranked 6/8 of platforms across the sample types) (Rose et al.,
2011). The QG-Mini80 also performed acceptably for extracting de-
tectable nucleic acid within clinically relevant ranges in this study.
This statement is contrasted by data presented here; RNA-based and
spore-forming organisms require more detailed optimization and in-
vestigation before recommended field use.
Prior to this research, it was unclear whether the irradiation pro-
cess would detrimentally impact real-time PCR which target smaller
amplicons than previous studies have evaluated (Lim et al., 2006;
Trampuz et al., 2006). Use of γ-irradiated biothreat agents in bio-
safety level 2 as a surrogate for viable agent is highly preferential
given the safety precautions required for working with biosafety
level 3+ organisms and the corollary fiscal impact. Comparing
data from γ-irradiated and viable agent extractions suggest marginal
impact on extraction efficacy and/or downstream detection. One coun-
terpoint to this statement specific to the QG-Mini80 is the extraction of
viable VEEV RNA. Real-time PCR results with γ-irradiated VEEV
showed better extraction for QIAamp; however, while results of
the QG-Mini80 were consistent, there were also dramatically
lower amounts of detectable RNA extracted for γ-irradiated com-
pared to QIAamp and non-existent amounts for viable agent. Lack
of sufficient extraction results with viable VEEV cannot be attribut-
ed to major sample differences as QIAamp extractions were com-
parable, viable or γ-irradiated. This may be a specific result to the
QG-Mini80 chemistry as this phenomenon has not been observed
previously in our lab. Reasons for poor and inconsistent performance
with viable VEEV could be attributed to a variety of factors, but
more research with the QG-Mini80 is required to draw any proper
conclusions.
Table 2
Real-time PCR based (CT) evaluation of the QuickGene-Mini80 and QIAamp purification
platforms of viable biothreat agents in whole blood.
Organism CFU/PFU/ml CT values for QG-Mini80a CT values for QIAampa
















± is the standard deviation of one real-time PCR assay from three replicates; nd = not
detected.
a A positive sample had a CT value b40 cycles, and a negative sample had a CT value
of >40 cycles.
b Two of three replicates gave valid results.
Table 3
Real-time PCR based (CT) evaluation of the QuickGene-Mini80 and QIAamp purification
platforms for B. anthracis spores in water.













± is the standard deviation of one real-time PCR assay from three replicates; nd = not
detected.
a A positive sample had a CT value b40 cycles, and a negative sample had a CT value
of >40 cycles.
b Two of three replicates gave valid results.
c One of three replicates gave valid results.
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The QG-Mini80's flexibility, portability, ease of use, and time-to-
answer are all considerations that make this instrument an attractive
alternative to column-based manual extractions. The QG-Mini80
has several advantages over its QIAamp counterpart currently rec-
ommended to field users. In 15–20 min, eight samples are ready for
PCR, an hour and a half faster than Qiagen. While both procedures uti-
lize affinity chromatography for nucleic acid capture, Qiagen columns
are centrifuged and transferred during each wash, dry, and elution
step whereas the QG-Mini80 columns are racked and remain station-
ary, allowing minimal sample handling and no centrifugation. This
would be ideal for extraction of DNA-based pathogens whereminimal
manipulation and aerosol generation are highly desired. In addition,
the QG-Mini80 is highly transportable with its compact size of 3 kg
and measurements of 22×28 in. The principle caveat is the compara-
tive performance. RNA-based purificationwas unacceptable, however,
results with DNA are adequate and within relevant target organism
ranges for diagnostic applications.
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